Funder
Amgen
Ministry of Food and Drug Safety
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Reference27 articles.
1. Wu J, Qu Y, Wang K, Chen Y (2019) Healthcare resource utilization and direct medical costs for patients with osteoporotic fractures in China. Value Health Reg Issues 18:106–111
2. Fujiwara S, Zhao X, Teoh C, Jaffe DH, Taguchi Y (2019) Disease burden of fractures among patients with osteoporosis in Japan: health-related quality of life, work productivity and activity impairment, healthcare resource utilization, and economic costs. J Bone Miner Metab 37(2):307–318
3. International Osteoporosis Foundation (2023) Epidemiology of osteoporosis and fragility fractures Available from:
https://www.osteoporosis.foundation/facts-statistics/epidemiology-of-osteoporosis-and-fragility-fractures. Accessed 20 Feb 2023
4. Williams SA, Chastek B, Sundquist K, Barrera-Sierra S, Leader D Jr, Weiss RJ et al (2020) Economic burden of osteoporotic fractures in US managed care enrollees. Am J Manag Care 26(5):e142–e1e9
5. Barron R, Oster G, Grauer A, Crittenden D, Weycker D (2020) Determinants of imminent fracture risk in postmenopausal women with osteoporosis. Osteoporos Int 31:2103–2111